These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7320842)

  • 1. Pharmacokinetics of indapamide in dogs.
    Grebow PE; Treitman JA
    J Pharm Sci; 1981 Dec; 70(12):1310-2. PubMed ID: 7320842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of bilateral nephrectomy on the pharmacokinetics of 14C-indapamide (REV 2555) and its metabolites in the dog.
    Klunk LJ; Mangat S; Treitman JA; Grebow PE
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):223-34. PubMed ID: 6658187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of indapamide--a new antihypertensive drug.
    Grebow PE; Treitman JA; Barry EP; Blasucci DJ; Portelli ST; Tantillo NC; Vukovich RA; Neiss ES
    Eur J Clin Pharmacol; 1982; 22(4):295-9. PubMed ID: 7106164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical pharmacology of indapamide.
    Caruso FS; Szabadi RR; Vukovich RA
    Am Heart J; 1983 Jul; 106(1 Pt 2):212-20. PubMed ID: 6869203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fostedil, a new calcium antagonist, in beagle dogs following oral and intravenous administration.
    Thomas EW; Bopp BA
    J Pharm Sci; 1984 Oct; 73(10):1400-3. PubMed ID: 6542139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
    Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
    AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.
    Pruss T; Wolf PS
    Am Heart J; 1983 Jul; 106(1 Pt 2):208-11. PubMed ID: 6869202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of some antihypertensive drugs on the metabolism and pharmacokinetics of indapamide in rats.
    Yan F; Hu Y; Di B; He PL; Sun G
    J Pharm Pharm Sci; 2012; 15(2):208-20. PubMed ID: 22579001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology and clinical pharmacology of indapamide.
    Campbell DB; Moore RA
    Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
    Acchiardo SR; Skoutakis VA
    Am Heart J; 1983 Jul; 106(1 Pt 2):237-44. PubMed ID: 6346847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of besulpamide in rats and dogs.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):121-6. PubMed ID: 3586769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and pharmacological properties of binding sites for the atypical thiazide diuretic, indapamide.
    Schaeffer P; Vigne P; Frelin C; Lazdunski M
    Eur J Pharmacol; 1990 Jul; 182(3):503-8. PubMed ID: 2226620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indapamide: its action in animals and man (author's transl)].
    Campbell DB
    Schweiz Rundsch Med Prax; 1982 Feb; 71(7):275-81. PubMed ID: 7111212
    [No Abstract]   [Full Text] [Related]  

  • 16. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric assay for urinary indapamide.
    Grebow PE; Treitman JA; Yeung AK
    J Pharm Sci; 1978 Aug; 67(8):1117-20. PubMed ID: 671249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.
    Holazo AA; Colburn WA; Gustafson JH; Young RL; Parsonnet M
    J Pharm Sci; 1984 Aug; 73(8):1108-13. PubMed ID: 6491914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro.
    Hermansen K; Schmitz O; Arnfred J; Mogensen CE
    Diabetes Res; 1986 May; 3(4):221-3. PubMed ID: 2874909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, metabolism and excretion of 14C-monoethyl phthalate (MEP) and 14C-diethyl phthalate (DEP) after single oral and IV administration in the juvenile dog.
    Kao ML; Ruoff B; Bower N; Aoki T; Smart C; Mannens G
    Xenobiotica; 2012 Apr; 42(4):389-97. PubMed ID: 22054055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.